日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Lynch Syndrome as a Spectrum of Four Distinct Genetic Disorders: Toward Genotype-Guided Precision Management in the NGS Era

林奇综合征：四种不同遗传疾病的谱系——迈向NGS时代基于基因型的精准管理

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18030506
Liu, Yuanyuan; Ye, Shengwei; Liu, Zhen; Chen, Zhen; Liang, Xinjun
发表日期：2026
文献求助 收藏

CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial

CLDN18.2靶向抗体药物偶联物IBI343治疗晚期胃癌或胃食管交界处腺癌：一项I期试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03783-8
Liu, Jia; Yang, Jianwei; Sun, Yuping; Gong, Jifang; Yue, Jinbo; Pan, Yueyin; Sun, Meili; Song, Rongfeng; Xiao, Xiuying; Tazbirkova, Andrea; Ruan, Jian; Liu, Zhenyang; Liu, Zimin; Li, Zhihua; Sheng, Lili; Qin, Yanru; Ying, Jieer; Yu, Xianjun; Zhang, Jian; Mou, Yiping; Lu, Chuangxin; Chen, Ping; Li, Suyi; Li, Jie; Qu, Xiujuan; Deng, Ting; Du, Juan; Zhou, Aiping; Li, Enxiao; Yuan, Xianglin; Liang, Xinjun; Yu, Weiming; Morris, Michelle; Luo, Yang; Zhao, Xin; Guo, Yingmei; Zhou, Hui; Shen, Lin
胃癌
CLDN1
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors

Givastomig（一种 CLDN18.2 和 4-1BB 双特异性抗体）作为单药疗法治疗 CLDN18.2 阳性晚期或转移性实体瘤患者的首次人体研究

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-4280
Ku, Geoffrey; Shen, Lin; Dayyani, Farshid; Kratz, Jeremy; Liang, Xinjun; Liu, Funan; Wang, Zhenning; Feller, Laura; Girda, Eugenia; Pan, Hongming; Kim, Sunnie; Deng, Yanhong; Deng, Ting; Liu, Tianshu; Powderly, John; Spencer, Kristen; Schneider, Reva; Berlin, Jordan; Xu, Claire Cong; Ahlers, Christoph M; Liu, Xuejun; Chung, Jou-Ku; Sabbatini, Peter; Park, Jinyoung; Lim, Yangmi; Jeon, Juyeun; Meng, Yuan; Klempner, Samuel J
CLDN1
Human
发表日期：2025
文献求助 收藏

Development and validation of a nomogram for predicting suicide risk factors in thyroid cancer patients following diagnosis: a population-based retrospective study

构建和验证用于预测甲状腺癌患者确诊后自杀风险因素的列线图：一项基于人群的回顾性研究

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1392283
Zhou, Jie; Tian, Mengjie; Zhang, Xiangchen; Xiong, Lingyi; Huang, Jinlong; Xu, Mengfan; Liang, Xinjun; Wei, Shaozhong
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study

帕博利珠单抗联合化疗一线治疗HER2阴性晚期胃癌：KEYNOTE-859随机3期研究的中国亚组分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03069-4
Qin, Shukui; Bai, Yuxian; Li, Jin; Pan, Hongming; Luo, Suxia; Qu, Yanli; Ye, Feng; Yang, Lin; Liu, Tianshu; Li, Wei; Chen, Xi; Yang, Jianwei; Ying, Jieer; Lin, Xiaoyan; Zhao, Lin; Liang, Xinjun; Mao, Yixiang; Guo, Run; Zuo, Yi; Bordia, Sonal; Li, Shouguo
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2025
文献求助 收藏

Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer

利用纳米材料靶向细胞凋亡：提高结直肠癌免疫疗法疗效的新途径

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1451067
Liu, Xiangdong; Zhang, Wanqiu; Wei, Shaozhong; Liang, Xinjun; Luo, Bo
肿瘤
肠癌
表观遗传
肿瘤免疫
凋亡
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Retraction Note: Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4(+)CCR6(+) Th/Treg cell subset imbalance in ankylosing spondylitis

撤稿声明：骨髓间充质干细胞免疫调节潜能降低导致强直性脊柱炎中CCR4(+)CCR6(+) Th/Treg细胞亚群失衡

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-024-03322-9
Wu, Yanfeng; Ren, Mingliang; Yang, Rui; Liang, Xinjun; Ma, Yuanchen; Tang, Yong; Huang, Lin; Ye, Jichao; Chen, Keng; Wang, Peng; Shen, Huiyong
T细胞
细胞生物学
Treg
干细胞
发育与干细胞
强直性脊柱炎
免疫/内分泌
发表日期：2024
文献求助 收藏

Clinical characteristics and treatment management of combined large cell neuroendocrine carcinoma, a subtype of large cell neuroendocrine carcinoma

混合型大细胞神经内分泌癌（大细胞神经内分泌癌的一个亚型）的临床特征和治疗管理

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1449490
Kang, Kai; Li, Binfeng; Wang, Sheng; Wang, Jianjian; Liang, Xinjun
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Optimizing the Strength and Toughness of V/Mo-Modified 0.22C-5.24Mn Steel by Short-Time Partial Austenitization Process

短时部分奥氏体化工艺优化V/Mo变质0.22C-5.24Mn钢的强韧性

期刊:Materials
影响因子:
doi:10.3390/ma17030687
Haoqing Zheng, Gang Liu, Shuai Tong, Guanqiao Su, Xiaokai Liang, Xinjun Sun
信号转导
发表日期：2024
文献求助 收藏

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial

信迪利单抗联合化疗治疗不可切除的胃癌或胃食管交界处癌：ORIENT-16随机临床试验

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2023.19918
Xu, Jianming; Jiang, Haiping; Pan, Yueyin; Gu, Kangsheng; Cang, Shundong; Han, Lei; Shu, Yongqian; Li, Jiayi; Zhao, Junhui; Pan, Hongming; Luo, Suxia; Qin, Yanru; Guo, Qunyi; Bai, Yuxian; Ling, Yang; Yang, Jianwei; Yan, Zhilong; Yang, Lei; Tang, Yong; He, Yifu; Zhang, Liangming; Liang, Xinjun; Niu, Zuoxing; Zhang, Jingdong; Mao, Yong; Guo, Yingmei; Peng, Bo; Li, Ziran; Liu, Ying; Wang, Yan; Zhou, Hui
肿瘤
肿瘤免疫
胃癌
发表日期：2023
文献求助 收藏